|Home | About | Journals | Submit | Contact Us | Français|
Through the definition of novel biological activities of hormones and their diversity on different skin cell types, it has become apparent that the skin itself possesses the capacity to generate several hormones and substances with hormone-like activity. These substances appear to act through paracrine, autocrine, intracrine and endocrine mechanisms to fulfill their pleiotropic effects. Also new is the knowledge that the skin can metabolize hormones and produce derivatives with potentially systemic activity. These findings point towards novel concepts in our understanding of the role of skin and of its hormones as important players in homeostasis and disorders of the entire human organism. Finally, the scientists active in the field of dermato-endocrinology expect that their activities will exploit the pharmacological and therapeutic function of hormone mediators, their receptors and antagonists. The latter idea has already been realized for corticosteroids, androgens, estrogens, topical vitamin D analogues and retinoids which have today an established place in clinical dermatology.
The historical picture of the endocrine system as a set of certain hormone-producing organs has been nowadays substituted by the concept of organized communities of organs in which the cells emit, receive and coordinate molecular signals from distant sources—such as the established endocrine organs— their neighbors, and themselves (Fig. 1). Complex endocrine mechanisms, such as expression and function of specific hormone receptors, synthesis of hormones from major classes of compounds used by the body for general purposes, elimination of the hormones in specialized skin cells, and exertion of biological activity have also been identified in the skin.1
Despite this knowledge, attention to the ability of human skin to fulfill the current requirements of the functions of an endocrine organ has only been drawn lately.2–5 The human skin has been classically regarded as the target for several hormones, whose effects have long been recognized and in some instances well characterized. For example, hair follicles and sebaceous glands are the targets for androgen steroids secreted by the gonads and the adrenal cortex.6,7 In addition, hormones play an important role in the development and the physiological function of human skin tissues,8,9 and, moreover, hormones are also produced in the skin. For example, the circulating androgens dehydroepiandrosterone (DHEA) and androstenedione are converted in the skin through different pathways to testosterone or androstenedione and further to in the periphery more potent androgen 5α-dihydrotestosterone (5α-DHT).10,11 Thus, from the modern dermato-endocrinologic point of view the skin is not only the recipient of signals from distant transmitters but is also an endocrine organ.12,13 New knowledge has rapidly accumulated in the last years on expression and function of specific hormone receptors,14 synthesis of hormones from major classes of compounds used by the body for general purposes,15 organized metabolism,10,11 activation, inactivation and elimination of the hormones in specialized cells of the skin,16 exertion of biological activity,7,17 and release of tissue hormones in the circulation.15,17
Hormones exert their biological effects on skin cells through binding and interaction with high-affinity receptors. The human skin expresses receptors for peptide hormones and neurotransmitters, which are mostly aligned on the cell surface, and those for steroid and thyroid hormones, which are found in the cytoplasm or nuclear compartments.1,7,15,18–20
Hormones exhibit pleiotropic biologic effects on the skin and appear to act through paracrine, autocrine, intracrine and endocrine mechanisms.1,12 Particularly, growth hormone/insulin-like growth factor-1, neuropeptides, sexual steroids, glucocorticoids, retinoids, vitamin D, peroxisome proliferator-activated receptor ligands and eicosanoids are major examples of hormones been active on the skin.1,14
Human skin produces hormones which are released in the circulation and are important for functions of the entire human organism.21 Major examples are sex steroids, whereas a large proportion of androgens and estrogens in men and women are synthesized locally in peripheral target tissues from the inactive adrenal precursors DHEA and androstenedione.10,11,16 DHEA and androstenedione are converted to testosterone or to 5α-DHT by different pathways through the involvement of the three isotypes of the intracellular enzyme 5α-reductase and of the isotypes of 17β-hydroxysteroid dehydrogenase,11,16 thus making the skin responsible for considerable amounts of the circulating 5α-DHT levels. The best estimate of the intracrine formation of estrogens in peripheral tissues in women is in the order of 75% before menopause and close to 100% after menopause, except for a small contribution from ovarian and/or adrenal testosterone and androstenedione.12 Thus, in postmenopausal women, almost all active sex steroids are made in target tissues by an intracrine mechanism.
Moreover, insulin-like growth factor (IGF)-binding protein-3 message levels are greater in the skin that in the liver and circulating IGF-binding protein-3 concentrations are significantly increased by growth hormone and IGF-1.22 GH has a direct function in the regulation of IGF-binding protein-3 synthesis, and the response of skin IGF-binding protein-3 mRNA levels to both GH and IGF-I suggests that dermal fibroblasts could be more important than the liver in the regulation of circulating reservoir IGF-binding protein-3 in certain circumstances.
At last but not least, human skin produces hormones which are released in the circulation and are permanently important for functions of the entire human organism, such as vitamin D.15 The skin is the unique site of cholecalciferol synthesis,23,24 which derives from cholesterol. Epidermal keratinocytes contain both the machinery needed to produce calcitriol and vitamin D receptor.15,25
In addition to its capacity to produce hormones the human skin is able to metabolize hormones in order to activate and inactivate them. These steps are overtaken in most cases by different skin cell populations in a coordinated way indicating the endocrine autonomy of the skin. Characteristic examples for this kind of endocrine skin function are the metabolic pathways of the corticotrophin-releasing hormone/propiomelanocortin axis, sex steroids, vitamin D and retinoids.1,15,26
Cardiovascular diseases due to atherosclerosis, being the commonest cause of mortality and morbidity in the western world, is directly related to disorders of lipid metabolism, diabetes mellitus and insulin resistance. Disorders of thyroid function and porphyrin metabolism occur less frequently but may cause life-threatening situations if not recognized. All these, at least partially, endocrinological disorders are associated with characteristic dermatoses, which should permit early diagnosis and meaningful intervention.27–30 Dermato-endocrinology seems to be wider than considered, even by those, who have initiated the field.
Treatment of skin diseases with with hormone mediators, of their receptors and antagonists is a common procedure in dermatology. Corticosteroids, androgens, estrogens, topical vitamin D analogues and retinoids have today an established place in dermato-pharmacology.13,15,18
Previously published online: www.landesbioscience.com/journals/dermatoendocrinology/article/9499